StockClub

TNGX

TNGXTango Therapeutics, Inc.$ --
Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

TNGX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -100.0%
Operating Income
-42M USD
YoY -2.3%
Net Income
-39M USD
YoY -2.9%
EPS
-0.3$
YoY +11.8%

Revenue

$62.4M
FY2024 Q1$6.5M
$6.5M
Q1
FY2024 Q2$26.3M
$26.3M
Q2
FY2024 Q3$38M
$38M
Q3
FY2024 Q4$42.1M
$42.1M
Q4
FY2025 Q1$5.4M
$5.4M
Q1
FY2025 Q2$8.6M
$8.6M
Q2
FY2025 Q3$62.4M
$62.4M
Q3
FY2025 Q4$62.4M
$62.4M
Q4
Actual
+$20.3M (+48.3%)

Net Income

$-101.6M
FY2024 Q1$-37.9M
$-37.9M
Q1
FY2024 Q2$-63.5M
$-63.5M
Q2
FY2024 Q3$-92.6M
$-92.6M
Q3
FY2024 Q4$-130.3M
$-130.3M
Q4
FY2025 Q1$-39.9M
$-39.9M
Q1
FY2025 Q2$-78.7M
$-78.7M
Q2
FY2025 Q3$-62.8M
$-62.8M
Q3
FY2025 Q4$-101.6M
$-101.6M
Q4
Actual
+$28.7M (+22.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$7.7M
FY2020
$7.7M
FY2021MISS
Actual:$37M
Est:$37.9M
FY2021MISS
$37M
FY2022BEAT
Actual:$24.9M
Est:$24.8M
FY2022BEAT
$24.9M
FY2023MISS
Actual:$36.5M
Est:$42.5M
FY2023MISS
$36.5M
FY2024MISS
Actual:$42.1M
Est:$46M
FY2024MISS
$42.1M
FY2025MISS
Actual:$62.4M
Est:$62.8M
FY2025MISS
$62.4M

Analyst Estimates